U-Blot® Research Grade SAR444200Cat. No. WA3508Request quote
Size: 50ug/100ug
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade SAR444200Cat. No. WA3508
U-Blot® Research Grade SAR442970Cat. No. WA3507
U-Blot® Research Grade SAR113244Cat. No. WA3506
U-Blot® Research Grade sanritatugCat. No. WA3505
U-Blot® Research Grade SamrotamabCat. No. WA3504
U-Blot® Research Grade SamatatugCat. No. WA3503
U-Blot® Research Grade SamalizumabCat. No. WA3502
U-Blot® Research Grade safimestomigCat. No. WA3501
U-Blot® Research Grade sacomitatugCat. No. WA3500
U-Blot® Research Grade SacituzumabCat. No. WA3499
U-Blot® Research Grade SabirnetugCat. No. WA3498
U-Blot® Research Grade SabestomigCat. No. WA3497